Thank you for Subscribing to Life Science Review Weekly Brief
Too often patient experiences are long, lonely, confusing, and financially troubling. It is easy for mistrust to build between pharma and patients, causing a decline in adherence, trial participation and health outcomes across all patient groups, especially underserved communities.